morphine-ADER-IMT

**Morphine-ADER-IMT** is an **abuse-deterrent, extended-release (ER) morphine formulation** produced using a proprietary **injection-molded tablet technology** (Guardian, originally developed by Egalet, now owned by Assertio). This manufacturing process incorporates a polymer matrix, resulting in a tablet with both strong physical and chemical barriers designed to resist tampering, crushing, or extraction. These features help deter abuse by limiting methods commonly used to prepare tablets for snorting or injection. The tablet forms a viscous hydrogel upon contact with liquid, further preventing manipulation for illicit routes of administration. It is clinically indicated for the treatment of **moderate to severe chronic pain** when alternative treatment options are inadequate. The abuse-deterrent properties have been demonstrated to lower the potential for misuse relative to non-abuse-deterrent morphine ER products[1][2][3][4][5][6].

Brand names

Arymo ER

Other names

morphine-ADER-IMTabuse-deterrent, extended-release injection-molded tabletsAD, ER injection-molded tablets